×
Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials.
Fletcher RA., Herrington WG., Agarwal R., Mayne KJ., Arnott C., Jardine MJ., Mahaffey KW., Perkovic V., Staplin N., Wheeler DC., Chertow GM., Heerspink HJL., Neuen BL.
DOI
10.2215/CJN.0000000000000470
Type
Journal article
Journal
Clin J Am Soc Nephrol
Publication Date
16/04/2024